Blue Trust Inc’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$711	Hold	158	–	–	﹤0.01%	2303
2025 Q4	$972	Hold	158	–	–	﹤0.01%	2289
2025 Q3	$1.14K	Sell	158 -81	-34%	-$481	﹤0.01%	2293
2025 Q2	$1.27K	Sell	239 -14,128	-98%	-$83.5K	﹤0.01%	2207
2025 Q1	$127K	Buy	14,367 +5,214	+57%	+$62.6K	﹤0.01%	892
2024 Q4	$125K	Sell	9,153 -3,510	-28%	-$64.8K	﹤0.01%	843
2024 Q3	$310K	Buy	12,663 +1,404	+12%	+$38K	﹤0.01%	658
2024 Q2	$240K	Buy	11,259 +2,365	+27%	+$51.9K	﹤0.01%	641
2024 Q1	$190K	Buy	8,894 +2,165	+32%	+$46.5K	﹤0.01%	525
2023 Q4	$109K	Buy	6,729 +1,186	+21%	+$20.5K	﹤0.01%	649
2023 Q3	$128K	Buy	5,543 +4,431	+398%	+$84.3K	﹤0.01%	552
2023 Q2	$26K	Sell	1,112 -10,266	-90%	-$224K	﹤0.01%	950
2023 Q1	$165K	Buy	11,378 +2,350	+26%	+$47.7K	﹤0.01%	607
2022 Q4	$172K	Buy	9,028 +4,589	+103%	+$85.5K	﹤0.01%	504
2022 Q3	$81K	Buy	4,439 +775	+21%	+$17.8K	﹤0.01%	604
2022 Q2	$92K	Buy	+3,664	New	+$76.1K	﹤0.01%	519